Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack

Title
Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack
Authors
Keywords
Pseudomonas aeruginosa, Complement system, Extracellular matrix proteins, Deletion mutagenesis, Immune serum, Bacterial pathogens, Heparin, Complement inhibitors
Journal
PLoS One
Volume 10, Issue 9, Pages e0137630
Publisher
Public Library of Science (PLoS)
Online
2015-09-15
DOI
10.1371/journal.pone.0137630

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started